Loading...
Loading...
India's fluoxetine imports from UNITED STATES total $38.2K across 98 shipments from 15 foreign suppliers. RAFF & HALL PHARMACY leads with $12.7K in import value; the top 5 suppliers together control 81.0% of this origin. Leading Indian buyers include TORRENT PHARMACEUTICALS LTD. This corridor reflects India's pharmaceutical import demand for fluoxetine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

RAFF & HALL PHARMACY is the leading Fluoxetine supplier from UNITED STATES to India, with import value of $12.7K across 3 shipments. The top 5 suppliers — RAFF & HALL PHARMACY, ESPEE BIOPHARMA & FINECHEM LLC, MS RAFF & HALL PHARMACY, M/S RAFF & HALL PHARMACY, AGRACE PHARMA — collectively account for 81.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RAFF & HALL PHARMACY | $12.7K | 3 | 33.1% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $10.2K | 11 | 26.8% |
| 3 | MS RAFF & HALL PHARMACY | $3.3K | 2 | 8.6% |
| 4 | M/S RAFF & HALL PHARMACY | $2.6K | 1 | 6.8% |
| 5 | AGRACE PHARMA | $2.2K | 11 | 5.7% |
| 6 | ESPEE BIOPHARMA FINECHEM LLC | $1.6K | 2 | 4.3% |
| 7 | NOVITIUM PHARMA LLC | $1.5K | 42 | 3.9% |
| 8 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $1.3K | 4 | 3.4% |
| 9 | AMSTERDAM PHARMA (APTEKA RX INC) | $684 | 1 | 1.8% |
| 10 | TIME-CAP LABS, INC. | $480 | 1 | 1.3% |
| 11 | GOOD HEALTH PARMA SUPPLIES | $404 | 2 | 1.1% |
| 12 | NEWLIFE MEDICALS (USA), INC. | $368 | 2 | 1.0% |
| 13 | GOOD HEALTH PHARMA SUPPLIES | $274 | 1 | 0.7% |
| 14 | GOOD HELTH PHARMA SUPPLIES | $267 | 1 | 0.7% |
| 15 | ANI PHARMACEUTICALS INC | $154 | 9 | 0.4% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TORRENT PHARMACEUTICALS LTD | $14.3K | 5 | 37.4% |
| 2 | AUROBINDO PHARMA LTD | $9.1K | 9 | 23.9% |
| 3 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $3.3K | 2 | 8.6% |
| 4 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $2.6K | 1 | 6.8% |
| 5 | NOVITIUM LABS PRIVATE LIMITED | $1.6K | 51 | 4.3% |
| 6 | LUPIN LIMITED | $1.6K | 7 | 4.2% |
| 7 | CADILA PHARMACEUTICALS LTD | $1.5K | 4 | 3.8% |
| 8 | PAR FORMULATIONS PRIVATE LIMITED | $1.3K | 4 | 3.4% |
| 9 | HETERO LABS LIMITED | $1.1K | 4 | 3.0% |
| 10 | IPCA LABORATORIES LIMITED | $684 | 1 | 1.8% |
| 11 | MARKSANS PHARMA LIMITED | $480 | 1 | 1.3% |
| 12 | HETERO LABS LIMITED | $274 | 1 | 0.7% |
| 13 | APOTEX RESEARCH PRIVATE LIMITED | $211 | 4 | 0.6% |
| 14 | ENEM NOSTRUM REMEDIES PRIVATE LIMITED | $46 | 1 | 0.1% |
| 15 | APL HEALTHCARE LIMITED | $12 | 2 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Fluoxetine suppliers from UNITED STATES to India include RAFF & HALL PHARMACY, ESPEE BIOPHARMA & FINECHEM LLC, MS RAFF & HALL PHARMACY. The leading supplier is RAFF & HALL PHARMACY with import value of $12.7K USD across 3 shipments. India imported Fluoxetine worth $38.2K USD from UNITED STATES in total across 98 shipments.
India imported Fluoxetine worth $38.2K USD from UNITED STATES across 98 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Fluoxetine sourced from UNITED STATES include TORRENT PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD, GRAVITI PHARMACEUTICALS PRIVATE LIMITED. The largest buyer is TORRENT PHARMACEUTICALS LTD with $14.3K in imports across 5 shipments.
The total value of Fluoxetine imports from UNITED STATES to India is $38.2K USD, across 98 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
98 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists